Skip to main content

Table 2 Selected ongoing clinical application of virus-based cancer vaccines (2016–2021)

From: Cancer vaccines as promising immuno-therapeutics: platforms and current progress

NCT number

Status

Targeted antigens/biological

Conditions

Phases

Category

NCT03136406

Active, not recruiting

mutant KRAS

Pancreatic Cancer

I/II

Virus vector

NCT03329248

Active, not recruiting

ALT-803, ETBX-011, GI-4000

Pancreatic Cancer

I/II

Virus vector

NCT03632941

Recruiting

HER2

Breast Cancer

II

Virus vector

NCT04410874

Recruiting

MUSIC-01

Non-melanoma Skin Cancer, Squamous /Basal Cell Carcinoma

I/II

Virus vector

NCT04432597

Recruiting

PRGN-2009

HPV-associated Cancers

I/II

Virus vector

NCT03815942

Active, not recruiting

ChAdOx1-MVA 5T4

Prostate Cancer

I/II

Virus vector

NCT03547999

Active, not recruiting

MVA-BN-CV301

Metastatic Colorectal Cancer

II

Virus vector

NCT03113487

Recruiting

p53

Recurrent Ovarian, Primary Peritoneal, Fallopian Tube Cancer

II

Virus vector

NCT04111172

Recruiting

Ad5.F35-hGCC-PADRE

Gastrointestinal Adenocarcinoma

II

Virus vector

NCT03315871

Recruiting

PROSTVAC-V/F, CV301

Prostate Cancer

II

Virus vector

NCT04574583

Active, not recruiting

MVA-BN-CV301

Metastatic Cancer, Solid Tumors

I/II

Virus vector

NCT02649855

Active, not recruiting

PROSTVAC-F/V

Prostate Cancer, Prostate Neoplasms, Neoplasms, Prostatic

II

Virus vector

NCT02933255

Recruiting

PROSTVAC-V/F

Prostate Cancer

I/II

Virus vector

NCT03563157

Active, not recruiting

MUC1, HER2, IL-15

Colorectal Cancer Metastatic, mCRC

I/II

Virus vector

NCT03953235

Recruiting

Neoantigens

Non-Small Cell Lung Cancer, Colorectal Cancer, Pancreatic Cancer, Solid Tumor

I/II

Virus vector/mRNA